Biomatrix scaffolds

• US 10,246,678 B2
• Filed: 07/27/2016
• Issued: 04/02/2019
• Est. Priority Date: 07/02/2010
• Status: Active Grant

• Current Assignee: University of North Carolina At Chapel Hill (University of North Carolina System)
• Original Assignee: University of North Carolina At Chapel Hill (University of North Carolina System)
• Inventors: Wang, Yunfang, Reid, Lola Cynthia McAdams, Yamauchi, Mitsuo, Cui, Cai-Bin, Wang, Andrew Zhuang, Werner, Michael Edward
• Primary Examiner(s): Paguio Frising, Michelle F.
• Application Number:
  US15/221,413
• Publication Number:
  US 20170015974A1
• Time in Patent Office: 979 Days
• Field of Search: None
• CPC Class Codes: A61L 2430/28 for liver reconstruction
• CPC Class Codes: A61L 27/24 Collagen
• CPC Class Codes: A61L 27/3604 characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
• CPC Class Codes: A61L 27/3683 subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
• CPC Class Codes: A61L 27/3691 characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
• CPC Class Codes: C12N 2500/25 Insulin-transferrin; Insulin-transferrin-selenium
• CPC Class Codes: C12N 2500/36 Lipids
• CPC Class Codes: C12N 2501/20 Cytokines; Chemokines
• CPC Class Codes: C12N 2501/998 Proteins not provided for elsewhere
• CPC Class Codes: C12N 2506/14 from hepatocytes
• CPC Class Codes: C12N 2533/54 Collagen; Gelatin
• CPC Class Codes: C12N 2533/90 Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
• CPC Class Codes: C12N 5/0068 General culture methods using substrates for specific animal cell type C12N5/06
• CPC Class Codes: C12N 5/067 Hepatocytes
• CPC Class Codes: C12N 5/0671 Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
• CPC Class Codes: C12N 5/0693 Tumour cells; Cancer cells
• CPC Class Codes: C12N 7/00 Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00

Abstract

The present invention provides biomatrix scaffolds, a tissue extract enriched for extracellular matrix components and bound growth factors, cytokines and hormones, and methods of making and using same.

Claims

1. A biomatrix scaffold produced by a method comprising:

a) perfusing the biological tissue or homogenizing the biological tissue from the group consisting of liver, lung, thyroid, skin, pancreas, blood vessels, bladder, kidneys, brain, biliary tree, duodenum, abdominal aorta, iliac vein, heart, and intestines, with a first medium, wherein the osmolality of said first medium is from about 250 mOsm/kg to about 350 mOsm/kg and said first medium is serum free and at neutral pH;

then

b) perfusing the biological tissue or extracting the homogenate of step (a) with a delipidating buffer comprising lipases and/or detergents in said first medium, wherein the detergents do not comprise sodium dodecyl sulfate or Triton X-100;

then

c) perfusing the tissue or extracting the homogenate of step (b) with a buffer at a neutral pH and comprising a salt concentration from about 2.0 M to about 5.0 M NaCl;

then

d) rinsing the tissue or homogenate of step (c) with a second medium that is at neutral pH, is serum-free and has an osomolality from about 250 mOsm/kg to about 350 mOsm/kg,

thereby producing an intact or homogenized biomatrix scaffold from the biological tissue, said biomatrix scaffold comprising at least 95% of the collagens and most collagen-associated matrix components and matrix bound growth factors, hormones and cytokines of the biological tissue.

2. A method of producing a cell culture, comprising:

a) contacting the biomatrix scaffold of claim 1 with cell culture medium in a culture apparatus; and

b) seeding the biomatrix scaffold of step (a) with cells, thereby producing a cell culture.

3. The method of claim 2, wherein the cell culture medium comprises at least one of the constituents present in interstitial fluid, wherein the osmolality of said medium is from about 250 mOsm/kg to about 350 mOsm/kg and wherein said medium is serum free.

4. The method of claim 3, wherein the medium is RPMI-1640.

5. The method of claim 2, wherein the cells are of the same type as the cells of the biological tissue used to make the biomatrix scaffold.

6. The method of claim 2, wherein the cells are selected from the group consisting of embryonic stem (ES) cells, induced pluripotent stem (iPS) cells, determined stem cells, perinatal stem cells, amniotic fluid-derived stem cells (AFSCs), mesenchymal stem cells (MSCs) from any source, committed progenitors or adult cells of any tissue type, mature cells, normal cells, diseased cells, tumor cells and any combination thereof.

7. The method of claim 2, wherein the cells are selected from the group consisting of liver cells, parenchymal cells, stellate cells, endothelial cells, hepatocytes, cholangiocytes, biliary tree cells that are not cholangiocytes and pancreatic cells.

8. A method of enhancing and accelerating differentiation of stem cells and/or progenitors to mature cells, comprising producing a cell culture according to the method of claim 2, wherein the cells are stem cells and the cell culture medium is formulated for mature cells, thereby enhancing and accelerating differentiation of stem cells and/or progenitors to mature cells.

9. The method of claim 8, wherein the cells are adult cells of any type or are stem cells or progenitors selected from the group consisting of embryonic stem cells, induced pluripotent stem cells, germ layer stem cells, determined stem cells, perinatal stem cells, amniotic fluid-derived stem cells, mesenchymal stem cells, transit amplifying cells or committed progenitors of any tissue type.

10. The method of claim 8, wherein the cell culture medium is selected from the group consisting of RPMI 1640, DME/F12, DME, F12, Waymouth'"'"'s, and William'"'"'s medium.

11. A method of producing a cell culture, comprising:

a) freezing the biomatrix scaffold of claim 1;

b) preparing a frozen section from the biomatrix scaffold of step (a) as a cell culture sub stratum;

c) contacting the cell culture substratum of step (b) with cell culture medium in a culture apparatus; and

d) seeding the cell culture substratum of step (c) with cells, thereby producing a cell culture.

12. The method of claim 11, wherein the cell culture-medium comprises at least one of the constituents present in interstitial fluid, wherein the osmolality of said medium is from about 250 mOsm/kg to about 350 mOsm/kg and wherein said medium is serum free.

13. The method of claim 12, wherein the medium is RPMI-1640.

14. The method of method of claim 11, wherein the cells are of the same type as the cells of the biological tissue used to make the biomatrix scaffold.

15. The method of claim 11, wherein the cells are selected from the group consisting of embryonic stem (ES) cells, induced pluripotent stem (iPS) cells, determined stem cells, perinatal stem cells, amniotic fluid-derived stem cells (AFSCs), mesenchymal stem cells (MSCs) from any source, committed progenitors or adult cells of any tissue type, mature cells, normal cells, diseased cells, tumor cells and any combination thereof.

16. The method of claim 11, wherein the cells are selected from the group consisting of liver cells, parenchymal cells, stellate cells, endothelial cells, hepatocytes, cholangiocytes, biliary tree cells that are not cholangiocytes and pancreatic cells.

17. A method of enhancing and accelerating differentiation of stem cells and/or progenitors to mature cells, comprising producing a cell culture according to the method of claim 11, wherein the cells are stem cells and the cell culture medium is formulated for mature cells, thereby enhancing and accelerating differentiation of stem cells and/or progenitors to mature cells.

18. The method of claim 17, wherein the cells are adult cells of any type or are stem cells or progenitors selected from the group consisting of embryonic stem cells, induced pluripotent stem cells, germ layer stem cells, determined stem cells, perinatal stem cells, amniotic fluid-derived stem cells, mesenchymal stem cells, transit amplifying cells or committed progenitors of any tissue type.

19. The method of claim 17, wherein the cell culture medium is selected from the group consisting of RPMI 1640, DME/F12, DME, F12, Waymouth'"'"'s, and William'"'"'s medium.

20. A method of producing a cell culture, comprising:

a) grinding the biomatrix scaffold of claim 1 to a powder;

b) coating at least part of a culture apparatus with the powder of step (a) to produce a cell culture substratum;

c) contacting the cell culture substratum of (b) with cell culture medium in the culture apparatus; and

d) seeding the cell culture substratum of (c) with cells, thereby producing a cell culture.

21. The method of claim 20, wherein the grinding of the biomatrix scaffold is carried out in a freezer mill at or near liquid nitrogen temperatures.

22. A method of producing virus particles of a lineage dependent virus, comprising:

a) contacting the biomatrix scaffold of claim 1 with cell culture medium in a culture apparatus;

b) seeding the biomatrix scaffold of (a) with cells of a type and lineage stage that can be infected with the lineage dependent virus;

c) infecting the cells of (b) with the lineage dependent virus;

d) maintaining the infected cells on the biomatrix scaffold under culture conditions; and

e) collecting virus particles produced in the infected cells,

thereby producing virus particles of the lineage dependent virus.

23. The method of claim 22, wherein the lineage dependent virus is selected from the group consisting of hepatitis C virus, hepatitis B virus, norovirus, and human papilloma virus.

24. A method of producing an organoid formed by recellularization of a biomatrix scaffold, comprising:

a) contacting the biomatrix scaffold of claim 1 with cell culture medium in a culture apparatus;

b) seeding the biomatrix scaffold of (a) with cells of the same tissue type as the biological tissue used to prepare the biomatrix scaffold; and

c) maintaining the cells on the biomatrix scaffold under culture conditions, whereby organoids form from the cells,

thereby producing an organoid formed by recellularization of the biomatrix scaffold.

25. The method of claim 24, further comprising the step of contacting the organoid with a subject, for use as an assist device.

26. The method of claim 24, wherein the cells are liver cells.

27. A cell culture substratum produced by a method comprising:

a) perfusing the biological tissue or homogenizing the biological tissue with a first medium, wherein the osmolality of said first medium is from about 250 mOsm/kg to about 350 mOsm/kg and said first medium is serum free and at neutral pH;

then

b) perfusing the biological tissue or extracting the homogenate of step (a) with a delipidating buffer comprising lipases and/or detergents in said first medium, wherein the detergents do not comprise sodium dodecyl sulfate or Triton X-100;

then

c) perfusing the tissue or extracting the homogenate of step (b) with a buffer at a neutral pH and comprising a salt concentration from about 2.0 M to about 5.0 M NaCl;

then

d) rinsing the tissue or homogenate of step (c) with a second medium that is at neutral pH, is serum-free and has an osomolality from about 250 mOsm/kg to about 350 mOsm/kg, thereby producing an intact or homogenized biomatrix scaffold from the biological tissue, said biomatrix scaffold comprising at least 95% of the collagens and most collagen-associated matrix components and matrix bound growth factors, hormones and cytokines of the biological tissue

e) freezing the biomatrix scaffold;

f) preparing a frozen section from the biomatrix scaffold of step (e) as a cell culture substratum.